Completing data — usually done within a minute
Basic information
- CAS
102676-31-3- Standard SMILES
Cl.N#Cc1ccc(C2CCCc3cncn32)cc1- InChIKey
UKCVAQGKEOJTSR-UHFFFAOYSA-N- Molecular formula
- C14H14ClN3
- Average molar mass
- 259.73 g/mol
- Monoisotopic mass
- 259.08762513
Overview
Fadrozole hydrochloride is an imidazopyridine.
Names & identifiers
- Preferred name
- Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-, hydrochloride (1:1)
- IUPAC
- 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile;hydrochloride
Names & synonyms
Show more names
Database identifiers
- CAS
102676-31-3- PubChem CID
- 59694
- DTXSID
DTXSID4020618- ChEMBL
CHEMBL468419- ChEBI
CHEBI:31589- UNII
- H0Q44H4ECQ
- EC Number
- 631-311-5
Properties
Computed structural propertiesFilling in
- Topological polar surface area
- 41.6 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 2
- Rotatable bonds
- 1
- Heavy atoms
- 18
- Formal charge
- 0
- Complexity
- 311
Safety & regulation
GHS classification
GHS Classification
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)
Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.
Suppliers43 total
Related reactions
Compound notes
Loading…